February 14, 2019
The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
HDA Statement on FDA Drug Importation Final Rule
September 25, 2020
In response to the Food and Drug Administration’s (FDA) final rule permitting prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released...
HDA Statement on COVID-19 Vaccine Distribution
August 14, 2020
Healthcare Distribution Alliance (HDA) President and CEO Chester "Chip" Davis, Jr., released the following statement regarding the distribution of COVID-19 vaccines and supplies through Operation Warp...
HDA Statement on the President's Drug Affordability Executive Orders
July 24, 2020
In response to President Trump signing drug pricing Executive Orders (EOs), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement.
HDA Outlines Principles for Pandemic and Public Health Emergency Response
June 11, 2020
The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during...
-
HDA Research Foundation Announces Inaugural Scholarship Recipients
-
AAOA Celebrates First Year of Working with Partners to Address the Opioid Epidemic Through EducationFebruary 13, 2019
This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
Media Contacts
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
